Firm probes more deaths tied to red yeast rice supplements

Japanese health supplement maker Kobayashi Pharmaceutical said it was probing 76 more deaths possibly linked to its tablets containing red yeast rice meant to lower cholesterol.

It deepens a scandal that erupted earlier this year when the company said it was looking into five deaths potentially linked to the over-the-counter products after dozens of customers reported kidney problems.